| |
| |
|
| Insider
Information: |
Mccourt Thomas A |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,156,374 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,580,517 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,156,374 |
|
|
| Total
Value |
$8,580,517 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
4
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -59.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ironwood Pharmaceuticals Inc |
IRWD |
|
2024-05-20 |
1,150,330 |
2013-03-11 |
0 |
Premium* |
|
|
Acceleron Pharma Inc |
XLRN |
Director |
2021-04-19 |
6,044 |
2017-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
21,875 |
74,513 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
President |
• – – |
2019-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,852 |
111,294 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-08-01 |
4 |
AS |
$11.35 |
$263,649 |
D/D |
(23,229) |
757,785 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2020-09-11 |
4 |
OE |
$30.17 |
$758,316 |
D/D |
23,272 |
27,694 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
Director |
– • – |
2020-09-11 |
4 |
AS |
$89.98 |
$2,103,466 |
D/D |
(23,272) |
4,422 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2017-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
54,300 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-09-01 |
4 |
AS |
$10.65 |
$281,650 |
D/D |
(26,446) |
731,339 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-05-30 |
4 |
AS |
$10.70 |
$284,962 |
D/D |
(26,632) |
758,284 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2017-05-15 |
4 |
S |
$18.20 |
$546,000 |
D/D |
(30,000) |
0 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2017-05-15 |
4 |
OE |
$5.48 |
$164,400 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2018-07-06 |
4 |
OE |
$5.48 |
$164,400 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2018-07-06 |
4 |
AS |
$20.00 |
$600,000 |
D/D |
(30,000) |
0 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-02-27 |
4 |
S |
$11.41 |
$342,346 |
D/D |
(30,004) |
712,581 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
30,145 |
742,585 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
S |
$11.31 |
$353,177 |
D/D |
(31,227) |
681,354 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-03-03 |
4 |
AS |
$11.22 |
$378,742 |
D/D |
(33,756) |
647,598 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-05-22 |
4 |
S |
$10.12 |
$364,320 |
D/D |
(36,000) |
784,916 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-05-23 |
4 |
AS |
$11.50 |
$417,542 |
D/D |
(36,308) |
798,881 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2013-03-11 |
4 |
OE |
$5.48 |
$219,200 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Commercial Officer |
• – – |
2013-03-11 |
4 |
AS |
$17.00 |
$680,000 |
D/D |
(40,000) |
0 |
0 |
- |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2023-03-27 |
4 |
AS |
$10.67 |
$492,196 |
D/D |
(46,129) |
842,064 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-12-22 |
4 |
AS |
$11.41 |
$528,591 |
D/D |
(46,327) |
574,454 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-02-28 |
4 |
AS |
$10.77 |
$521,526 |
D/D |
(48,424) |
586,320 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2021-11-23 |
4 |
AS |
$11.58 |
$609,618 |
D/D |
(52,644) |
618,545 |
0 |
% |
|
| IRWD |
Ironwood Pharmaceuticals ... |
Chief Executive Officer |
• • – |
2022-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
60,290 |
634,744 |
0 |
- |
|
68 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
